High dose dipyridamole as a pharmacological stress test during cardiac catheterisation in patients with coronary artery disease

Heart

Volumn 75, Issue 3, 1996, Pages 247-251

  Wagdi, Philipp ^a,b   Kaufmann, Urs ^a   Fluri, Martin ^a   Meier, Bernhard ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Coronary stenosis severity; Dipyridamole; Ischaemic heart disease; Stress testing

Indexed keywords

DIPYRIDAMOLE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; EXERCISE; FEMALE; HEADACHE; HEART CATHETERIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VERTIGO;

EID: 0029928056     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.3.247     Document Type: Article

References (18)

1. Taillefer R. Technetium-99m Sestamibi myocardial imaging: same-day rest-stress studies and dipyridamole. Am ℑ Cardiol 1990;66:80-84E.
2. Marwick T, Willemart B, D'Hont A, et al. Selection of the optimal nonexercise stress test for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Circulation 1993;87:345-54.
3. Picano E. Dipyridamole-echocardiography test: historical background and physiologic basis. Eur Heart ℑ 1989;10:365-76.
4. Gates CU, Kronenberg MW, Collins HW, Sandler MP. Dipyridamole radionuclide ventriculography: A test with high specificity for severe coronary artery disease. ℑ Am Coll Cardiol 1989;13:841-51.
5. 201TI versus MUGA. Eur ℑ Nucl Med 1982;7:1-5.
6. Mazeika P, Nihoyannopoulos P, Joshi J, Oakley C. Uses and limitations of high dose dipyridamole stress echocardiography for evaluation of coronary artery disease. Br Heart ℑ 1992;67:144-9.
7. Picano E, Landi P, Bolognese L, et al. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: A large scale multicenter trial. Am ℑ Med 1993;95:608-18.
8. Moles VP, Meier B, Pande AK. PTCA at first sight: angioplasty based on video only. ℑ Invas Cardiol 1992;4:344-8.
9. Aroesty JM, Mc Kay RG, Heller GV, Royal HD, Als AV, Grossmann W. Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia. Circulation 1985;71:889-900.
10. Vogel RA. The impact of health care reform on cardiac imaging. Curr Opin Cardiol 1993;8:975-7.
11. Crawford MH, Petru MA, Amon KW, Sorensen SG, Vance WS. Comparative value of 2-dimensional echocardiography and radionuclide ventriculography for quantitating changes in left ventricular performance during exercise limited by angina pectoris. Am ℑ Cardiol 1984; 53:42-6.
12. Ogilvie RI, Fernandez PG, Winsberg F. Cardiovascular response to increasing theophylline concentrations. Eur ℑ Clin Pharmacol 1977;12:409-14.
13. Aguirre FV, Pedersen W, Castello R, et al. The effects of high (sodium meglumine diatrizoate, Renografin-76) and low osmolar (sodium meglumine ioxaglate, Hexabrix) radiographic contrast media on diastolic function during left ventriculography in patients. Am Heart ℑ 1991;121:848-57.
14. Ritchie JL, Nissen SE, Douglas JS, et al. Use of nonionic or low osmolar contrast agents in cardiovascular procedures. ℑ Am Coll Cardiol 1993;21:269-73.
15. Gerber KH, Higgins CB, Yuh YS, Koziol JA. Regional myocardial hemodynamic and metabolic effects of ionic and nonionic contrast media in normal and ischemic states. Circulation 1982;65:1307-14.
16. Lattanzi F, Picano E, Bolognese L, et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans: correlation with exercise electrocardiography. Circulation 1991;83:1256-62.
17. Fung AY, Gallagher KP, Buda AJ. The physiological basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation 1987;76:943-51.
18. Fronek A, Hofbauer KG, Kalusche D, et al. Heart rate. In: Lentner C, ed. Geigy scientific tables. Heart and circulation. Basel: Ciba Geigy, 1990:16.